Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer
Open Access
- 4 October 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (61) , 103055-103062
Abstract
Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancerKeywords
This publication has 28 references indexed in Scilit:
- EGFR Testing in Advanced Non–Small-Cell Lung Cancer, A Mini-ReviewClinical Lung Cancer, 2016
- The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysisOncotarget, 2016
- Challenges in molecular testing in non-small-cell lung cancer patients with advanced diseaseThe Lancet, 2016
- Could molecular pathology testing in lung cancer be more cost-effective?Journal of Clinical Pathology, 2016
- The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016Journal of Thoracic Oncology, 2016
- Overall survival benefits of first-line EGFR tyrosine kinase inhibitors in EGFR-mutated non-small-cell lung cancers: a systematic review and meta-analysisBritish Journal of Cancer, 2015
- Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancerAnnals of Oncology, 2015
- A Comparison of Methods for EGFR Mutation Testing in Non–Small Cell Lung CancerDiagnostic Molecular Pathology, 2013
- Pitfalls in Lung Cancer Molecular Pathology: How to Limit them in Routine Practice?Current Medicinal Chemistry, 2012
- Usefulness of tissue microarrays for assessment of protein expression, gene copy number and mutational status of EGFR in lung adenocarcinomaVirchows Archiv, 2010